https://scholars.lib.ntu.edu.tw/handle/123456789/626296
標題: | Integrated therapy platform of exosomal system: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment | 作者: | Chan M.-H Chang Z.-X Huang C.F Lee L.J RU-SHI LIU Hsiao M. |
公開日期: | 2022 | 卷: | 7 | 期: | 4 | 起(迄)頁: | 352-367 | 來源出版物: | Nanoscale Horizons | 摘要: | Recent studies have found that exosomes or extracellular vehicles (EVs) are associated with cancer metastasis, disease progression, diagnosis, and treatment, leading to a rapidly emerging area of exocrine vesicle research. Relying on the superior targeting function and bio-compatibility of exosomes, researchers have been able to deliver drugs to cancer stem cells deep within tumors in mouse models. Despite significant efforts made in this relatively new field of exosome research, progress has been held back by challenges such as inefficient separation methods, difficulties in characterization/tracking, and a lack of specific biomarkers. Therefore, current researches are devoted to combining nanomaterials with exosomes to improve these shortcomings. Adding inorganic/organic nanoparticles such as artificial liposomes and iron oxide can bring more drug options and various fluorescent or magnetic diagnostic possibilities to the exosome system. Moreover, the applications of exosomes need to be further evaluated under actual physiological conditions. This review article highlights the potential of exosome-biomimetic nanoparticles for their use as drug carriers to improve the efficacy of anticancer therapy. © 2022 The Royal Society of Chemistry |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124874311&doi=10.1039%2fd1nh00637a&partnerID=40&md5=7bd5d846a4ad87f53724b45491446e77 https://scholars.lib.ntu.edu.tw/handle/123456789/626296 |
ISSN: | 20556756 | DOI: | 10.1039/d1nh00637a | SDG/關鍵字: | Biomimetics; Diagnosis; Diseases; Liposomes; Stem cells; Targeted drug delivery; Bio-compatibility; Cancer metastasis; Disease diagnosis; Disease progression; Disease treatment; Exosomes; Extracellular; Hybrid inorganic-organic; Metastasis disease; Organic nanoparticles; Iron oxides; drug carrier; nanoparticle; animal; drug delivery system; exosome; mouse; neoplasm; Animals; Drug Carriers; Drug Delivery Systems; Exosomes; Mice; Nanoparticles; Neoplasms |
顯示於: | 化學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。